Peptron, Inc.

KOSDAQ:A087010 Stock Report

Market Cap: ₩6.0t

Peptron Valuation

Is A087010 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of A087010 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: Insufficient data to calculate A087010's future cash flow value for valuation analysis.

Significantly Below Future Cash Flow Value: Insufficient data to calculate A087010's future cash flow value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A087010?

Key metric: As A087010 barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for A087010. This is calculated by dividing A087010's market cap by their current book value.
What is A087010's PB Ratio?
PB Ratio42.1x
Book₩142.01b
Market Cap₩5.98t

Price to Book Ratio vs Peers

How does A087010's PB Ratio compare to its peers?

The above table shows the PB ratio for A087010 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average28.3x
A141080 LigaChem Biosciences
11.4x98.47%₩5.8t
A445680 Curiox Biosystems
28.1xn/a₩1.5t
A207940 Samsung BiologicsLtd
8.3x11.98%₩65.5t
A187660 Penetrium Bioscience
65.6xn/a₩447.4b
A087010 Peptron
42.1xn/a₩6.0t

Price-To-Book vs Peers: A087010 is expensive based on its Price-To-Book Ratio (42.1x) compared to the peer average (28.3x).

Historical Price to Book Ratio

Historical Price to Book Ratio compares a stock's price to the book value of it's equity over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Book Ratio vs Industry

How does A087010's PB Ratio compare vs other companies in the KR Life Sciences Industry?

3 CompaniesPrice / BookEstimated GrowthMarket Cap
A225220 Genolution
0.5xn/aUS$21.59m
A043090 TechnologyLtd
0.2xn/aUS$3.46m
A036180 GW VitekLTD
0.007xn/aUS$125.43k
No more companies available in this PB range
A087010 42.1xIndustry Avg. 2.1xNo. of Companies6PB02.85.68.411.214+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: A087010 is expensive based on its Price-To-Book Ratio (42.1x) compared to the KR Life Sciences industry average (2.1x).

Price to Book Ratio vs Fair Ratio

What is A087010's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A087010 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio42.1x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate A087010's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/24 23:15
End of Day Share Price 2026/05/22 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Peptron, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wan KuNH Investment & Securities Co., Ltd.